NCLT Approves Resolution Plan for RITE BUILTEC PRIVATE LIMITED
Resolution achieved in overall 450 Days, ending a 15-Year wait for over…
NCLT Approves Resolution Plan for RITE BUILTEC PRIVATE LIMITED
Resolution achieved in overall 450 Days, ending a 15-Year wait for over…
NCLT Approves Resolution Plan for RITE BUILTEC PRIVATE LIMITED
Resolution achieved in overall 450 Days, ending a 15-Year wait for over…
Masdar’s Capacity Up By 150% to Over 50GW In Two Years Cementing Place as Global Clean Energy Leader
Masdar's operational, under construction and advanced pipeline capacity grew from 20GW to…
Masdar’s Capacity Up By 150% to Over 50GW In Two Years Cementing Place as Global Clean Energy Leader
Masdar's operational, under construction and advanced pipeline capacity grew from 20GW to…
Commercial Chapter 11 Filings Increase 20 Percent in Calendar Year 2024
NEW YORK and ALEXANDRIA, Va., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Commercial…
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
December 11, 2024 07:05 ET | Source: Celcuity Inc. Median overall survival…
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
Based on more than six months of additional monitoring, data show continued…
Climate Giving Surges 20% in 2023, Outpaces Growth in Global Philanthropy
New report highlights five years of climate philanthropy trends: record growth, geographic…
DARZALEX (daratumumab) subcutaneous formulation shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smouldering multiple myeloma
First subcutaneous anti-CD38 therapy to demonstrate potential to prevent end-organ damage, and…